Legal & General Group PLC Reata Pharmaceuticals Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $250,731 - $333,496	-3,165 Reduced 11.87%	23,498 $2.4 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $79,994 - $241,589	2,593 Added 10.77%	26,663 $2.42 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $25,118 - $47,752	-1,134 Reduced 4.5%	24,070 $914,000
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $40,023 - $75,242	2,062 Added 8.91%	25,204 $634,000
Q2 2022 Aug 22, 2022	BUY	$20.71 - $36.5 $17,810 - $31,390	860 Added 3.86%	23,142 $703,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $434 - $712	-18 Reduced 0.08%	22,282 $730,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $1,203 - $5,215	47 Added 0.21%	22,300 $588,000
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $518,600 - $741,701	5,186 Added 30.39%	22,253 $2.24 Million
Q2 2021 Aug 12, 2021	BUY	$78.27 - $151.29 $31,464 - $60,818	402 Added 2.41%	17,067 $2.42 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $60,697 - $85,529	644 Added 4.02%	16,665 $1.66 Million
Q4 2020 Feb 12, 2021	SELL	$102.03 - $184.62 $295,376 - $534,474	-2,895 Reduced 15.3%	16,021 $1.98 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $7,014 - $12,250	-75 Reduced 0.39%	18,916 $1.84 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $623,543 - $871,676	4,937 Added 35.13%	18,991 $2.96 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $98,707 - $196,953	795 Added 6.0%	14,054 $2.03 Million
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $235,044 - $686,883	3,152 Added 31.19%	13,259 $2.71 Million
Q3 2019 Nov 13, 2019	BUY	$71.26 - $95.75 $436,681 - $586,756	6,128 Added 154.01%	10,107 $811,000
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $22,383 - $27,172	288 Added 7.8%	3,979 $376,000
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $14,376 - $28,195	277 Added 8.11%	3,691 $315,000
Q4 2018 Feb 15, 2019	BUY	$48.76 - $76.44 $17,163 - $26,906	352 Added 11.5%	3,414 $192,000
Q3 2018 Nov 20, 2018	BUY	$35.64 - $92.06 $21,277 - $54,959	597 Added 24.22%	3,062 $250,000
Q2 2018 Aug 10, 2018	BUY	$19.94 - $40.96 $9,910 - $20,357	497 Added 25.25%	2,465 $86,000
Q1 2018 May 17, 2018	SELL	$20.0 - $30.19 $22,140 - $33,420	-1,107 Reduced 36.0%	1,968 $40,000
Q4 2017 Feb 13, 2018	BUY	$22.39 - $33.27 $68,849 - $102,305	3,075	3,075 $86,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account